SSG
VRA

Summit Securities Group’s VIRAGEN INC NEW VRA Stock Holding History

Summit Securities Group’s Portfolio VRA Stock Details VRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-230,000
Closed – – 664
2015
Q1 		$0 Hold
230,000
– – ﹤0.01% 774
2014
Q4 		$0 Hold
230,000
– – ﹤0.01% 849
2014
Q3 		$0 Hold
230,000
– – ﹤0.01% 887
2014
Q2 		$0 Hold
230,000
– – ﹤0.01% 732
2014
Q1 		$0 Hold
230,000
– – ﹤0.01% 709
2013
Q4 		$0 Hold
230,000
– – ﹤0.01% 676
2013
Q3 		$0 Hold
230,000
– – ﹤0.01% 714
2013
Q2 		$0 Buy
+230,000
New – ﹤0.01% 651

Summit Securities Group's VRA Position: Q2 2015 in Review

Summit Securities Group sold out of VIRAGEN INC NEW (VRA) in Q2 2015, closing a stake of 230,000 shares.

Summit Securities Group first reported a position in VRA in Q2 2013 and held it in 8 quarters. The position peaked at $0 in Q1 2015. 0 funds tracked by Wall St. Rank hold VRA as of Q2 2015.

  • Summit Securities Group reported no remaining VIRAGEN INC NEW position as of Q2 2015 after selling out during the quarter.
  • Summit Securities Group sold 230,000 VIRAGEN INC NEW shares in Q2 2015.
  • Summit Securities Group first reported a position in VIRAGEN INC NEW in Q2 2013 and held it in 8 quarters.
  • Summit Securities Group's VIRAGEN INC NEW position peaked at $0 in Q1 2015.
  • 0 funds tracked by Wall St. Rank held VIRAGEN INC NEW as of Q2 2015.

Based on Summit Securities Group's 13F filing for Q2 2015, filed 5 Aug 2015.